Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04060446
Other study ID # I 68718
Secondary ID NCI-2019-04530I
Status Completed
Phase
First received
Last updated
Start date June 6, 2019
Est. completion date March 2, 2020

Study information

Verified date July 2022
Source Roswell Park Cancer Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This trial examines the effects of filter ventilation on sensory response, smoking topography, and inhalation in current every day cigarette smokers. The physical design features of cigarettes directly impact their appeal by influencing cognitive and sensory perceptions. The introduction of a now common design feature, filter ventilation, has led to greater public harm than benefit because of the potential for greater toxicity while enhancing product appeal among smokers. Ventilated cigarettes dilute smoke, which promotes perceptions of ?smoothness? and therefore lower health risk, contributing to the overall appeal of these products. The purpose of this study is to assess whether removing ventilation from cigarette filters lowers cigarette product appeal among smokers.


Description:

PRIMARY OBJECTIVES: I. To assess the link between marketing proxies for filter ventilation (product descriptors, packaging) and risk beliefs. OUTLINE: Patients smoke 5 cigarettes separated by 30 minute washout periods. Between 48 hours and 1 week later, patients smoke another 5 cigarettes separated by 30 minute washout period with CReSSMicro topography measurement device and BioRadio device for recording inhalation patterns.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date March 2, 2020
Est. primary completion date March 2, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria: - Currently smoking daily at least 5 cigarettes per day for at least one year - Primarily using factory-made filtered cigarettes with filter ventilation - Fair and above physical health - Fair and above mental health - Not actively trying to quit smoking or planning to quit in the next 30 days - Able to converse, read, and write in English - No alcohol or illegal drug use - Not pregnant or breastfeeding Exclusion Criteria: - Currently smoking daily less than 5 cigarettes per day for at least one year - Using roll-your-own cigarettes or unventilated filter cigarettes - Currently using any other tobacco product daily - Actively trying to quit smoking or planning to quit in the next 30 days - Not able to converse, read, and write in English - Adults unable to consent - Prisoners - Poor physical health by self report - Poor mental health by self report - Alcohol and illegal drug use - Pregnant or breastfeeding by self report

Study Design


Intervention

Device:
Medical Device
Smoke cigarettes with CReSSMicro topography measurement device and BioRadio device
Other:
Questionnaire Administration
Ancillary studies
Behavioral:
Tobacco Smoking
Smoke cigarettes

Locations

Country Name City State
United States Roswell Park Cancer Institute Buffalo New York

Sponsors (3)

Lead Sponsor Collaborator
Roswell Park Cancer Institute National Cancer Institute (NCI), University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Cigarette Evaluation Questionnaire Scored using an established algorithm. This results in 3 subscales (psychological reward, relief, reward) and 2 single items (aversion, respiratory sensation). Up to 210 minutes
Secondary Carbon monoxide (CO) boost Defined as the difference between pre-smoking exhaled CO and postsmoking exhaled CO. Up to 210 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT03691350 - Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs Early Phase 1
Completed NCT01967082 - APPSPIRE App in Preventing Students From Smoking N/A
Recruiting NCT03865472 - rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers N/A
Active, not recruiting NCT02271919 - Varenicline and Combined NRT for Smoking Cessation Phase 4
Withdrawn NCT03668769 - Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking N/A
Completed NCT02575885 - Nicotine Delivery From Novel Non-Tobacco Electronic System in Smokers N/A
Completed NCT00941395 - Enhanced Smoking Cessation for University Students N/A
Recruiting NCT03199651 - Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer N/A
Recruiting NCT03824535 - 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules Phase 2
Completed NCT00468234 - Validation of Biomarkers of Exposure and Host Response N/A
Completed NCT00850954 - Project CASA in Promoting Smoke-Free Indoor Air Policy in Mexican American Households N/A
Active, not recruiting NCT02697227 - Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation N/A
Completed NCT03669120 - Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking N/A
Completed NCT00948129 - Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers N/A